Solvay Sa · EURONEXT:SOLB

Solvay Sa — Solvay Sa Act — Q2 2026 Earnings Presentation

22 slides from Solvay Sa's earnings presentation, Jul 29, 2026

  1. Slide 1: Second Quarter 2026 Results

    Second Quarter 2026 Results July 29, 2026 Philippe KEHREN Alexandre BLUM CEO CFO

  2. Slide 2: Forenote

    Forenote This presentation may contain forward-looking information. Forward-looking statements describe expectations, plans, strategies, goals, future events or intentions. The achievement of forward-looking statements contained in this presentation is subject to risks and uncertainties relating to

  3. Slide 3: Table of Contents

    TABLE OF CONTENTS 01 Introduction Philippe Kehren 02 Financials Alexandre Blum 03 Rare Earths Philippe Kehren 04 Outlook Philippe Kehren 05 Q&A

  4. Slide 4: Introduction

    Philippe KEHREN 01 INTRODUCTION 4

  5. Slide 5: Safety at the heart of our operations

    Safety at the heart of our operations 0.5 15 0.45 13 0.4 0.33 0.33 11 0.35 0.30 0.31 0.30 0.29 0.29 9 0.3 0.27 0.26 0.24 0.25 7 0.2 4 4 5 0.15 3 3 3 3 0.1 1 1 0.05 0 0 0 1 0 -1 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 2024 2024 2024 2024 2025 2025 2025 2025 2026 2026 High severity reportable injuries Reportabl

  6. Slide 6: Key messages

    For Information Key messages Bicarbonate and Peroxides performing well PERFORMANCE Pricing pressure on seaborne soda ash Coatis recovery HEADWINDS FROM THE MIDDLE EAST HPPO temporary shutdown in Saudi Arabia EU ETS REFORM Going in the right direction, confirming carbon neutrality by 2050 6

  7. Slide 7: Financials

    Alexandre BLUM 02 FINANCIALS

  8. Slide 8: Q2/H1 2026 results

    Q2/H1 2026 results Impacted by soda ash headwinds and Middle East conflict €1.0bn €187m €48m €15m €1.8bn Underlying Underlying Underlying NET SALES EBITDA COST SAVINGS FREE CASH FLOW1 NET DEBT YTD YTD June 2026 Q2 2026 Q2 2026 -7.4% (organic basis) -19.5% (organic basis) €26m in Q2 €-11m in Q2 2.3x

  9. Slide 9: Q2 underlying Net Sales bridge

    Q2 underlying Net Sales bridge Volumes down yoy, though sequentially up vs Q1 Volumes down yoy (-5.3%) 1,102 - +12 -58 -24 1,031 Peroxides plant shutdown in Jubail Scope Forex c. €-20m 2025 Special Chem contract termination conversion Volume Price & mix Lower pricing (-2.2%) Pricing pressure in soda

  10. Slide 10: Q2 underlying EBITDA bridge

    Q2 underlying EBITDA bridge Majority of volume decline yoy due to non-recurring elements MARGIN -2.8pp MARGIN Volume & mix 20.9% 18.1% c. €-20m 2025 Special Chem contract termination negative mix driven by lower HPPO Peroxides sales 230 - +2 -62 Scope Forex conversion -1 +10 +8 187 Net pricing Impro

  11. Slide 11: Basic Chemicals results

    Basic Chemicals results Continued headwinds for seaborne soda ash and effect from Middle East Q2 2026 (€m) % YoY % YoY organic Soda Ash & Deriv. 404 -9% -8% Peroxides 218 -4% -5% uNet Sales 622 -7% -7% uEBITDA 134 -6% -6% uEBITDA Margin 21.5% Q2 Soda Ash & Soda ash volumes down due to delayed shipme

  12. Slide 12: Performance Chemicals results

    Performance Chemicals results Clear recovery of Coatis, overall sequential improvement Q2 2026 (€m) % YoY % YoY organic Silica 130 -3% -3% Coatis 131 +10% +1% Special Chem 148 -18% -18% Net Sales 409 -6% -8% uEBITDA 78 -24% -26% uEBITDA Margin 19.2% Q2 Silica Resilient but unfavorable regional mix H

  13. Slide 13: FCF generation of €15m in H1

    FCF generation of €15m in H1 Usual seasonality and transformation expenses impacting H1 Capex €-141m, strict discipline in Capex spending 406 -141 Working Capital €-79m consistent with usual seasonality -79 Capex -106 Working Provisions capital -30 €-106m still above normalized level from -34 Pro vi

  14. Slide 14: Temporary cash impacts on FCF

    Temporary cash impacts on FCF (in m€) Transformation expenses still weighing on cash generation in 2026 Stranded costs 2025 2026 2027 Negative impact on EBITDA 0 -30 ERP (opex and capex) -25 -27 Higher in 2025-2026 -40 -50 -50 Restructuring cash-outs -71 • Fluorine and post-TSA 2025-2026 Restructuri

  15. Slide 15: Capital structure

    Capital structure Net debt temporarily increased following dividend payments S&P RATING: BBB- Stable outlook -254 -10 17 -1,829 -1,597 15 In/outflow from M&A Oth er Underlying net debt: FCF to Solvay share- Dividen ds to Solvay share- €1.8 Bn holders holders Employee benefits liabilities: €0.6 Bn En

  16. Slide 16: Rare Earths

    Philippe KEHREN 03 Rare Earths

  17. Slide 17: Rare Earths - Solvay's expertise

    Rare Earths - Solvay’s expertise Solvay is present in the separation, purification & formulation steps of the value chain SOURCING SEPARATION & FORMULATION MAIN APPLICATIONS END MARKETS Mixed Rare Automotive Earth Oxides Catalysis formulation Footprint: Electronics 3 production CMP slurries, MLCC si

  18. Slide 18: Rare Earths - Developments

    Rare Earths - Developments La Rochelle separation capacities Accelerating opportunities at La Rochelle With more than 75 years of experience, Solvay is the only company outside of China with the technical know-how to separate all 17 rare earth elements. Magnets light rare earths (NdPr) in production

  19. Slide 19: Outlook

    Philippe KEHREN OUTLOOK SOLVAY

  20. Slide 20: 2026 Outlook Confirmed

    2026 OUTLOOK CONFIRMED Anticipating the restart of Peroxides plant in Saudi Arabia in Q3 Underlying EBITDA Free Cash Flow 2 Capex Between Minimum Around €770 & €850 million1 €200 million €300 million (net of €40 million of (net of €90 million of transformation expenses) transformation expenses) 1 As

  21. Slide 21: Q&A

    Q&A SOLVAY

  22. Slide 22: Thank You

    THANK YOU Visit solvay.com Visit solvay.com Contact media relations Contact investor relations 22

Solvay Sa Act — Q2 2026 Earnings Presentation on 6ix